Status: Ongoing
First registered on:
02/03/2022
Last updated on:
29/08/2022
1. Study identification
EU PAS Register NumberEUPAS46057
Official titleQuantitative structure Activity Relationships (QSAR) for nitrosamine risk assessment. EMA/2020/46/TDA/01(Lot 1) SC01 under FWC EMA/2020/46/TDA/L1.02
Study title acronymQSAR for Nitrosamines
Study typeOther: research project
Brief description of the studyDevelopment of a structure activity relationship for N-Nitrosamines. A special focus will be given to the evaluation of DNA adduct formation and DNA repair processes by experimental testing. With these data, groups of highly potent carcinogens will be distinguished form less potent Nitrosamines. This knowledge will allow to set different thresholds for Nitrosamines.
Was this study requested by a regulator?Yes: EMA
Is the study required by a Risk Management Plan (RMP)?
Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre nameFraunhofer Gesellschaft
Centre locationFraunhofer Institute for Toxicology and Experimental Medicine
Details of (Primary) lead investigator
Title Dr
Last name Escher
First name Sylvia
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Not applicable (single centre)
Countries in which this study is being conducted
International study
Germany
Netherlands
United Kingdom
United States
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed08/12/202108/12/2021
Start date of data collection01/01/202203/01/2022
Start date of data analysis
Date of interim report, if expected28/02/202228/02/2022
Date of final study report31/12/2023
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government bodyEMA100
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Escher
First name Sylvia
Address line 1Nikolai-Fuchs str. 1
Address line 2
Address line 3
CityHannover
Postcode30161
CountryGermany
Phone number (incl. country code)49-162-2916659
Alternative phone number
Fax number (incl. country code)
Public Enquiries
Title Dr
Last name Escher
First name Sylvia
Address line 1Nikolai-Fuchs str. 1
Address line 2
Address line 3
CityHannover
Postcode30161
CountryGermany
Phone number (incl. country code)49-162-2916659
Alternative phone number
Fax number (incl. country code)
6. Study drug(s) information
Not applicable (disease/epidemiology study)
7. Medical conditions to be studied
Medical condition(s)No
8. Population under study
Age
Adolescents (12 - 17 years)
Sex
Male
Female
9. Number of subjects
Estimated total number of subjects0
10. Source of data
Is this study being carried out with an established data source?No
Sources of data
Section 8 and 9 are not applicable, but I cuold not leave the fields open. Therefore the information given there is not correct. This project is about research. In the project testing of DNA adduct formation and DNA repair in relevant in vitro test systems will be carried out. A clinical study is not envisaged.
11. Scope of the study
What is the scope of the study?
Risk assessment
Primary scope : Risk assessment
12. Main objective(s)
What is the main objective of the study?
Distinguish classes of Nitrosamines, which differ with regard to their carcinogenic potential.
Are there primary outcomes?Yes
Structural rules which defines properties that lead to high or low carcinogenic potency.
Are there secondary outcomes?No
13. Study design
What is the design of the study?
research study testing in vitro assays
14. Follow-up of patients
Will patients be followed up?Not applicable/no follow-up
15. Data analysis plan
Please provide a brief summary of the analysis method
Derivation of acceptable daily intake values for classes of Nitrosamines
16. ENCePP seal
Are you requesting the ENCePP seal for this study?
No
17. Full protocol
18. Study Results
Not submitted
Please list the 5 most relevant publications using data from your study
ReferenceLink to web-publication
None
19. Other relevant documents
Conflict(s) of interest of
investigator(s)Not submitted
Composition of Steering Group and
ObserversNot submitted
Other documentsNot
submitted
Signed Code of
Conduct Checklist
Not submitted
Signed Code of Conduct Declaration
Not submitted
Signed Checklist for Study
Protocols
Not submitted
